ECSP982539A - INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER - Google Patents
INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCERInfo
- Publication number
- ECSP982539A ECSP982539A ECSP982539A ECSP982539A EC SP982539 A ECSP982539 A EC SP982539A EC SP982539 A ECSP982539 A EC SP982539A EC SP982539 A ECSP982539 A EC SP982539A
- Authority
- EC
- Ecuador
- Prior art keywords
- inhibitors
- hmg coa
- coa reductase
- cancer treatment
- combined
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title 1
- 229950008696 farnesil Drugs 0.000 title 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title 1
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 title 1
- 239000003558 transferase inhibitor Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un procedimiento para tratar cáncer en un mamífero, incluida un ser humano, administrando al citado mamífero un inhibidor de la FTSA combinado con un inhibidor de la HMG CoA.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982539 ECSP982539A (es) | 1998-06-16 | 1998-06-16 | INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982539 ECSP982539A (es) | 1998-06-16 | 1998-06-16 | INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982539A true ECSP982539A (es) | 1999-02-11 |
Family
ID=42043459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982539 ECSP982539A (es) | 1998-06-16 | 1998-06-16 | INHIBIDORES DE LA FARNESIL TRANSFERASA COMBINADOS CON INHIBIDORES DE LA HMG CoA REDUCTASA PARA EL TRATAMIENTO DEL CANCER |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982539A (es) |
-
1998
- 1998-06-16 EC ECSP982539 patent/ECSP982539A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
| DK1169060T3 (da) | Natriumkanalblokkerpræparater og anvendelse deraf | |
| MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
| BR0316238A (pt) | Quimioterapia de associação compreendendo um inibidor de mek e capecitabina para tratamento de câncer | |
| HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
| BRPI0408476A (pt) | métodos para melhorar a qualidade da pele | |
| BR0013081A (pt) | Pirimidino-2,4,6-trionas inibidoras de metaloproteinases | |
| IL147017A0 (en) | TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES | |
| BR9811099A (pt) | Inibidores de urocinase | |
| EA200500859A1 (ru) | Хинолинилпирролопиразолы | |
| MY138883A (en) | Use of asiatic acid for treatment of cencer | |
| EP1098642A4 (en) | METHODS OF TREATING MODULATED CONDITIONS WITH LACTOSYLCERAMIDE | |
| ATE510553T1 (de) | Beta-2-glycoprotein 1 als angiogenesehemmer | |
| DE60019121D1 (de) | Kaliumkanäleöffner | |
| ATE430572T1 (de) | Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie | |
| IL162384A0 (en) | Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases | |
| PA8453601A1 (es) | Inhibidores de la farnesil transferasa combinados con inhibidores de la hmg coa reductasa para tratamiento del cancer | |
| UY27772A1 (es) | Inhibidores triariloxiariloxipirimidin-2,4,6- triona de metaloproteinasa. | |
| BR0315942A (pt) | Tratamento de doenças e condições mediadas pelo aumento de fosforilação | |
| ATE327973T1 (de) | Polyamin-analoge als cytotoxische wirkstoffe | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| TR200002203T2 (tr) | Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi. | |
| EA200100930A1 (ru) | Способ лечения хозл | |
| SE0100684D0 (sv) | New subject-matter | |
| PL357179A1 (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers |